Thank you, readers! That's all from CNBCTV18.com's live market coverage on August 25, 2022. Stay tuned for other updates on our website: CNBCTV18.com.
You can follow us on Twitter: @CNBCTV18Live @CNBCTV18News
And on Facebook, LinkedIn, Instagram and Telegram
Download our mobile app for Android and iOS platforms
Nifty50 gained 593 pts in August F&O series
Here are some highlights of the August series:
--Headline indices gain for second straight series
--Midcap index rises more than six percent
--Barring Nifty IT and Nifty Pharma, all sectoral indices rise
--Nifty Metal gains the most, up nearly 10 percent
--38 Nifty stocks rise — Eicher, Bharti Airtel, Bajaj Finserv top gainers
--Divi’s, Sun Pharma and Britannia top Nifty losers
--REC, RBL, IDFC First Bank, Tata Chemicals, IDFC top non-Nifty F&O gainers
--Intellect, Indus Towers, PVR, Shriram Transport top non-Nifty F&O losers
Market At Close | Sensex and Nifty50 make a sharp-U-turn in fag-end of expiry day
Here are some highlights:
--Shree Cement, Hindalco, Divi’s, Eicher and SBI Life top Nifty gainers
--Bajaj Finance, Cipla, IndusInd, Axis Bank and TCS top Nifty losers
--Bharti Airtel declines after Singtel sells three percent stake in it to Bharti Telecom
--Balkrishna Industries falls two percent following negative brokerage note
--Nippon Life down three percent as stock moves out of F&O from next series
--Adani group stocks slip — Adani Ports and Adani Enterprises fall two percent
--Coromandel drops four percent after government issues new packaging rule for sector
--Market breadth remains in favour of the bulls — advance-decline ratio at 5:4
Like pharma space because of its high cashflow nature, RoE, RoC and pricing power: Abhisar Jain
Abhisar Jain, Head and Fund Manager at Monarch AIF, tells CNBC-TV18 that he likes the domestic branded generic space within the pharma space because of its high cashflow, high RoE, RoC and pricing power nature. "We also like the CRO and CDMO space wherein global innovators are increasingly outsourcing business to countries like India, where costs are low and the work is good. We also like hospitals in the pharma space," he says.
Apart from pharma, Jain says Monarch is positive on consumer discretionary-low ticket items like electricals, value, apparel, and wires and cables as the festive season demand could be good. "The wage hikes and the overall economy is doing well. And also we see that there will be some margin tailwinds because the commodities have softened from their recent highs," he adds.
Jackson Hole Symposium 2022
The meeting starts today (August 25) and will go on till August 27. It will see US Federal Reserve chair Jerome Powell address the current global economic challenges, and it is widely expected that the tone will be "hawkish". (Here's more)
Buy Crompton Consumer, Aditya Birla Capital: Ruchit Jain
Here are two recommendations by Ruchit Jain of 5paisa.com
-- Buy Crompton Consumer for a target of Rs 445 with a stop loss at Rs 390
-- Buy Aditya Birla Capitai for a target of Rs 127 with a stop loss at Rs 109
TCS stock was listed today, 18 years ago
Indian technology giant Tata Consultancy Services (TCS) shares that complete 18 years since the listing today have given 282.9 percent returns to investors on their investment in IPO during the period. (Here's more)
Buy United Spirits, Canara Bank: Jay Thakkar
Here are two recommendations by Jay Thakkar of Marwadi Shares & Financials
-- Buy United Spirits for a target of Rs 870 with a stop loss at Rs 802
-- Buy Canara Bank for a target of Rs 253 with a stop loss at Rs 236